Casma Therapeutics
With deep expertise in cellular degradation, Casma is advancing targeted therapies for neurodegeneration and beyond.
10 employees · est. 2018 · Cambridge, United States
MapLight Therapeutics, Inc.
Creating breakthrough innovative therapeutics for serious CNS disorders
144 employees · est. 2018 · Redwood City, United States
MapLight Therapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Casma Therapeutics | MapLight Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2018 |
| Headquarters | ||
| Headquarters | Cambridge, United States | Redwood City, United States |
| Employees | ||
| Employees | 10 | 144 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biopharma, Biotechnology, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series C | Series C |
| Total Funding | ||
| Total Funding | $162.47M | $268.10M |
| Funding Rounds | ||
| Funding Rounds | 5 | 4 |
| Services | ||
| Services | Reprogramming autophagy for disease treatment, Development of novel cellular degradation approaches, Autophagy-based drug discovery and development, Target-specific autophagic degradation | Discovery Platform Development, Innovative Therapeutic Development, Clinical Trials for CNS Conditions, Strategic Collaborations for New Treatments |
| Target Customers | ||
| Target Customers | Healthcare Professionals, Biopharmaceutical Researchers, Patients with Oncology, Inflammation, Neurodegeneration, and Metabolic Disorders | Patients with Brain Disorders, Healthcare Providers, Research Institutions, Investors in Biotechnology |
| Taxonomy | ||
| Taxonomy | Autophagy, Drug Discovery, Lysosomal Storage Disorders, Muscle Disorders, Inflammatory Disorders, Neurodegeneration, Cellular Processes, Medicine Development, Therapeutics, Medical Research, Biopharmaceuticals | Biopharmaceutical, Innovative Therapeutics, CNS Disorders, Central Nervous System, Drug Discovery, Single-cell Transcriptomics, Optogenetics, Novel Drug Targets, Brain Disorders, Therapeutic Development, Biotech Platform, Neurology, Precision Medicine, Drug Development |
| Website | ||
| Website | casmatx.com | maplightrx.com |
About Casma Therapeutics
Casma Therapeutics, founded in 2018 and headquartered in the United States, is shaping the future of the Biotechnology and Health Care industries through innovative research. With the slogan, "Harnessing the power of autophagy to bring cures to patients with serious diseases," the company focuses on...
About MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc., established in 2018, is a promising player in the biopharmaceutical arena, focused on developing breakthrough innovations for serious central nervous system (CNS) disorders. Known for its commitment to transformative therapies, the company's core mission aligns with its...
We will tell you when either one moves
BounceWatch watches Casma Therapeutics and MapLight Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Casma Therapeutics and MapLight Therapeutics,... — by email.
Frequently Asked Questions
Compare Casma Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Casma Therapeutics on 12 Sep 2024, and MapLight Therapeutics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
